Neumora Therapeutics Inc (NMRA)
1.1300 x 20 1.1900 x 16
Post-market by (Cboe BZX)
1.1300 -0.0300 (-2.59%) 03/21/25 [NASDAQ]
1.1300 x 20 1.1900 x 16
Post-market 1.1300 unch (unch) 16:22 ET
for Fri, Mar 21st, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | |
| Operating Expenses | 263,464 | 252,098 | 135,870 |
| Operating Income | -263,464 | -252,098 | -135,870 |
| Other Income | 19,855 | 16,441 | 4,966 |
| Pre-tax Income | -243,609 | -235,657 | -130,904 |
| Income Tax | 178 | 268 | N/A |
| Net Income Continuous | -243,787 | -235,925 | -130,904 |
| Net Income | $-243,787 | $-235,925 | $-130,904 |
| EPS Basic Total Ops | -1.53 | -3.63 | -4.81 |
| EPS Basic Continuous Ops | -1.53 | -3.63 | -4.81 |
| EPS Diluted Total Ops | -1.53 | -3.63 | -4.81 |
| EPS Diluted Continuous Ops | -1.53 | -3.63 | -4.81 |
| EPS Diluted Before Non-Recurring Items | -1.53 | -3.63 | -4.81 |
| EBITDA(a) | $-268,552 | $-255,171 | $-135,984 |